A few things:
1) many foreign countries not only fix the prices, but threaten to not recognize patents for companies that don’t comply. There are several ways that the prices are fixed, ranging from dictating the price, to limiting the price to merely production costs plus a percentage (forcing the cost of development onto US customers alone). Having already sunk the cost of development into the drug, it is more profitable to then extend the market into the other countries than not.
2) is it gouging to set a high price for something that was never available before? Real gouging is jacking up the price because your competitor has been banned from selling. It is not merely having a price that is more than your buyer wants it to be. Higher prices bring more investment. Educated, stable strong investment generally brings more breakthroughs.
3) It is a bad thing that the US population is subsidizing pharmaceutical breakthroughs for the rest of the world. It is a worse thing to bring the engine to a halt. We need the national willpower to address this issue - and not in the leftist way of spreading the misery.
“3) It is a bad thing that the US population is subsidizing pharmaceutical breakthroughs for the rest of the world. It is a worse thing to bring the engine to a halt. We need the national willpower to address this issue - and not in the leftist way of spreading the misery.”
It is a big big-pharma lie. More than half of big pharma is not U.S. based and does R&D not just in the U.S. but in their home bases - U.K., Sweden, Swiss, France & Germany, as well as other places they have operations as well.